These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2915539)

  • 1. Assessment of serial carcinoembryonic antigen: determinations to monitor the therapeutic progress and prognosis of metastatic liver disease treated by regional chemotherapy.
    Quentmeier A; Schlag P; Hohenberger P; Schwarz V; Abel U
    J Surg Oncol; 1989 Feb; 40(2):112-8. PubMed ID: 2915539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of serial carcinoembryonic antigen (CEA): monitor to evaluate efficacy of continuous intrahepatic chemotherapy for nonresectable liver metastases of colorectal carcinomas].
    Yasuno M; Mori T; Takahashi K
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1556-9. PubMed ID: 7574758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of Carcinoembryonic Antigen Ratio and Response Evaluation Criteria in Solid Tumors as Prognostic Surrogate Indicators of Metastatic Colorectal Cancer Patients Treated with Chemotherapy.
    Huang SC; Lin JK; Lin TC; Chen WS; Yang SH; Wang HS; Lan YT; Lin CC; Jiang JK; Chang SC
    Ann Surg Oncol; 2015 Jul; 22(7):2262-8. PubMed ID: 25586242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of tumor marker CEA, CA 19-9 in regional chemotherapy of hepatic metastases of colorectal carcinoma.
    Safi F; Roscher R; Bittner R; Beger HG
    Int J Biol Markers; 1988; 3(2):101-6. PubMed ID: 2977396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen half-life is an early predictor of therapeutic effects in induction chemotherapy for liver metastases from colorectal cancer.
    Nagai Y; Beppu T; Sakamoto Y; Miyamoto Y; Hayashi H; Nitta H; Imai K; Masuda T; Okabe H; Hirashima K; Imamura Y; Baba Y; Chikamoto A; Baba H
    Anticancer Res; 2014 Oct; 34(10):5529-35. PubMed ID: 25275051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use and limitations of serial plasma carcinoembryonic antigen (CEA) levels as a monitor of changing metastatic liver tumor volume in patients receiving chemotherapy.
    Bronstein BR; Steele GD; Ensminger W; Kaplan WD; Lowenstein MS; Wilson RE; Forman J; Zamcheck N
    Cancer; 1980 Jul; 46(2):266-72. PubMed ID: 6446377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?
    Krischke W; Niederle N; Schütte J; Pfeiffer R; Hirche H
    Cancer; 1988 Oct; 62(7):1348-54. PubMed ID: 2843279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of CEA determination in follow-up of patients with liver metastasis of colorectal cancers with loco-regional chemotherapy].
    Schimpfle B; Matthias M; Wolff H; Mai C; Lüning M
    Zentralbl Chir; 1991; 116(1):45-50. PubMed ID: 2038900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival.
    Aabo K; Pedersen H; Kjaer M
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):211-7. PubMed ID: 3699082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of serum CEA fall after hepatic arterial chemotherapy as sole therapy and combined with cryotherapy for colorectal metastases.
    Hocking RA; Morris DL
    Aust N Z J Surg; 1998 Oct; 68(10):722-4. PubMed ID: 9768609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential carcinoembryonic antigen levels. A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer.
    Ichiki AT; Krauss S; Israelsen KL; Sonoda T; Collmann IR
    Oncology; 1981; 38(1):27-30. PubMed ID: 7443173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre- and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis.
    Hohenberger P; Schlag PM; Gerneth T; Herfarth C
    Ann Surg; 1994 Feb; 219(2):135-43. PubMed ID: 8129484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2002; 49(44):388-92. PubMed ID: 11995458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of analytical CEA doubling time and half-life time for overlooked synchronous metastases in colorectal carcinoma.
    Ito K; Hibi K; Ando H; Hidemura K; Yamazaki T; Akiyama S; Nakao A
    Jpn J Clin Oncol; 2002 Feb; 32(2):54-8. PubMed ID: 11948229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study.
    Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Hirayama Y; Hieda N; Yoshida T; Okuno N; Shimizu Y; Niwa Y; Yamao K
    Pancreatology; 2016; 16(5):859-64. PubMed ID: 27256641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
    Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
    J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relation between serum carcinoembryonic antigen (CEA) and response to chemotherapy in patients with advanced colorectal cancer].
    Shimano T; Monden T; Morimoto H; Mori T
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):423-8. PubMed ID: 2321973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of CEA and LDH in relation to KRAS status in patients with unresectable colorectal liver metastases.
    Connell LC; Boucher TM; Chou JF; Capanu M; Maldonado S; Kemeny NE
    J Surg Oncol; 2017 Mar; 115(4):480-487. PubMed ID: 28008623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.
    Kim IH; Lee JE; Yang JH; Jeong JW; Ro S; Lee MA
    Asia Pac J Clin Oncol; 2018 Jun; 14(3):239-246. PubMed ID: 29044941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.